BP861

Kanamycin monosulfate

British Pharmacopoeia (BP) Reference Standard

Manufacturer: Sigma Aldrich

CAS Number: 25389-94-0

Synonym(S): Kanamycin A sulfate salt

Select a Size

Pack Size SKU Availability Price
50 MG BP861-50-MG In Stock ₹ 24,789.25

BP861 - 50 MG

₹ 24,789.25

In Stock

Quantity

1

Base Price: ₹ 24,789.25

GST (18%): ₹ 4,462.065

Total Price: ₹ 29,251.315

grade

pharmaceutical primary standard

API family

kanamycin

form

powder

quality

British Pharmacopoeia (BP) Reference Standard

shelf life

limited shelf life, expiry date on the label

manufacturer/tradename

BP

application(s)

pharmaceuticalpharmaceutical small molecule

format

neat

storage temp.

2-8°C

InChI

1S/C18H36N4O11.H2O4S/c19-2-6-10(25)12(27)13(28)18(30-6)33-16-5(21)1-4(20)15(14(16)29)32-17-11(26)8(22)9(24)7(3-23)31-17;1-5(2,3)4/h4-18,23-29H,1-3,19-22H2;(H2,1,2,3,4)/t4-,5+,6-,7-,8+,9-,10-,11-,12+,13-,14-,15+,16-,17-,18-;/m1./s1

Other Options

Image Product Name Manufacturer Price Range
Tocris Bioscience™ Kanamycin Sulfate
-- --
TOKU-E Kanamycin Sulfate USP, 25389-94-0, 5 g
-- ₹ 5,963.00
TOKU-E Kanamycin ReadyMade™ Solution, 25389-94-0, 100 ML
-- ₹ 5,429.00
Kanamycin Sulfate Pharmaceutical Secondary Standard, MilliporeSigma™ Supelco™
-- ₹ 13,047.40
Sigma Aldrich Fine Chemicals Biosciences Kanamycin sulfate United States Pharmacopeia (USP) Reference Standard | 25389-94-0 | 200mg
-- ₹ 47,632.80
Kanamycin Sulfate
-- ₹ 10,760.05
Kanamycin sulfate
-- ₹ 40,756.13
Kanamycin sulfate from Streptomyces kanamyceticus
-- ₹ 5,618.18 - ₹ 61,561.78
Kanamycin solution from Streptomyces kanamyceticus
-- ₹ 8,475.98
Kanamycin solution from Streptomyces kanamyceticus
-- ₹ 2,652.13

Related Products

Img

Sigma Aldrich

BP743

British Pharmacopoeia (BP) Referenc...

Img

Sigma Aldrich

BP636

British Pharmacopoeia (BP) Referenc...

Img

Sigma Aldrich

BP776

British Pharmacopoeia (BP) Referenc...

Img

Sigma Aldrich

BP669

British Pharmacopoeia (BP) Referenc...

Description

  • General description: This product is provided as delivered and specified by the issuing Pharmacopoeia. All information provided in support of this product, including SDS and any product information leaflets have been developed and issued under the Authority of the issuing Pharmacopoeia. For further information and support please go to the website of the issuing Pharmacopoeia.
  • Application: Kanamycin monosulfate BP Reference standard, intended for use in laboratory tests only as specifically prescribed in the British Pharmacopoeia. Also used in monographs such as:Tobramycin and Dexamethasone Eye Drops, SuspensionTobramycin Inhalation Powder, Hard CapsuleTobramycin Nebuliser SolutionTobramycin Oral SolutionTobramycin Eye DropsTobramycin InjectionTobramycin SulfateStreptomycin Sulfate for Injection
  • Packaging: Unit quantity: 50 mg. Subject to change. The product is delivered as supplied by the issuing Pharmacopoeia. For the current unit quantity please visit British Pharmacopoeia
  • Other Notes: Sales restrictions may apply.

SAFETY INFORMATION

Pictograms

GHS08

Signal Word

Danger

Hazard Statements

H360D

Precautionary Statements

P201 - P202 - P280 - P308 + P313 - P405 - P501

Hazard Classifications

Repr. 1B

WGK

WGK 2